Jannine Poletti Hughes

Jannine Poletti Hughes is a Senior Lecturer in Accounting and Finance at the University of Liverpool's Management School, specializing in corporate finance with emphasis on governance, gender diversity, bankruptcy, and pharmaceutical sector performance. Her work bridges academic research and practical policy implications in global markets.

Education:

• PhD in Economics, University of York

Her research centers on corporate governance mechanisms, particularly gender diversity's impact on board effectiveness, fraud prevention, and risk management. Recent work examines pharmaceutical orphan drug approvals and bankruptcy prediction models, using behavioral agency theory to analyze director decision-making. She investigates how board composition influences corporate outcomes like default risk and earnings management across family and non-family firms.

Publication trends reveal strong focus on gender diversity reforms (especially UK vs. international comparisons), board independence in familial cultures, and pharmaceutical sector economics. Her work consistently applies cross-cultural analysis to governance failures, with pharmaceutical research emerging as a distinct stream since 2016.

Awards and Honors:

• Prize on Corporate Finance Research (IMEF and EY, 2022)
• 1st prize on Corporate Finance Research IMEF-EY 2021 (2021)
• 2nd place Adalberto Viesca Sada prize (2021)
• 1st place Adalberto Viesca Sada prize (2019)
• National Research Institute Fellow (CONACYT, 2019)
• Invited Professor, Universidad Autonoma de San Luis Potosi (2017)
• Corporate Finance Research Award (IMEF and EY, 2016)
• Highest Corporate Finance Research Award (IMEF and EY, 2015)
• National Researchers Scheme Fellow (CONACYT, 2015)
• Best in Session Award (Business and Finance Research, 2011)
• Four-year Prize Fellowship (CONACYT, 2000)

She collaborates internationally with researchers from Hull, Bradford, Bangor, and Mexican institutions. Her SLAS-funded 2017 workshop on Latin American corruption demonstrates regional expertise. As Chair of the Management School's Equality, Diversity and Inclusion Committee, she integrates governance research with institutional leadership. External roles include SLAS Treasurer (2021-2024) and Business Association for Latin American Studies committee membership.

Her research connects with Organisational and Employee Wellbeing groups, focusing on governance-cultural interactions. Pharmaceutical sector work involves analyzing orphan drug economics through policy lenses, while Latin American collaborations examine corruption and family firm governance in emerging markets.